PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells (Review)

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.4, Iss.1, 2016-01, pp. : 13-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted therapy against cancer stem cells (Review)

By Yang Tao Rycaj Kiera

Oncology Letters, Vol. 10, Iss. 1, 2015-07 ,pp. : 27-33

Spandidos Publications

Access to resources Recommend Favorite

Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (Review)

By Liang Chen Li Ying-Yi

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-06 ,pp. : 2051-2060

Spandidos Publications

Access to resources Recommend Favorite

Chk1 knockdown confers radiosensitization in prostate cancer stem cells

By Wang Xiaobin Ma Zhikun Xiao Zheng Liu Hui Dou Zhongling Feng Xiaoshan Shi Haijun

Oncology Reports, Vol. 28, Iss. 6, 2012-12 ,pp. : 2247-2254

Spandidos Publications

Access to resources Recommend Favorite

Targeting Prostate Cancer Stem Cells

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1105-1113

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer stem cells and cancer therapy

By Soltanian Sara

Tumor Biology, Vol. 32, Iss. 3, 2011-06 ,pp. : 425-440

Springer Publishing Company

Access to resources Recommend Favorite